NEE
75
4
QCOM
46
2
MTB
71
3
TMO
60
2
HOG
45
3
MOS
26
-3
MUR
38
3
AMP
67
3
F
59
3
CCL
58
3
DE
48
5
VRTX
57
8
ORCL
32
3
FAST
46
4
XYL
49
6
ADBE
44
3
BDX
61
2
LH
53
-2
RIG
57
3
GM
79
4
NEE
75
4
QCOM
46
2
MTB
71
3
TMO
60
2
HOG
45
3
MOS
26
-3
MUR
38
3
AMP
67
3
F
59
3
CCL
58
3
DE
48
5
VRTX
57
8
ORCL
32
3
FAST
46
4
XYL
49
6
ADBE
44
3
BDX
61
2
LH
53
-2
RIG
57
3
GM
79
4
Financhill
Back

AbbVie, Inc. 10K Form

Buy
59

ABBV
AbbVie, Inc.

Last Price:
$228.65
Seasonality Move:
5.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-03 10Q ABBV/AbbVie, Inc. Quarterly
2023-11-06 10Q ABBV/AbbVie, Inc. Quarterly
2023-08-07 10Q ABBV/AbbVie, Inc. Quarterly
2023-05-05 10Q ABBV/AbbVie, Inc. Quarterly
2022-11-04 10Q ABBV/AbbVie, Inc. Quarterly
2022-08-04 10Q ABBV/AbbVie, Inc. Quarterly

Receive ABBV News And Ratings

See the #1 stock for the next 7 days that we like better than ABBV

ABBV Financial Statistics

Sales & Book Value

Annual Sales: $56.3B
Cash Flow: $6.6B
Price / Cash Flow: 20.72
Annual Sales: $-1.49
Price / Book: 247.77

Profitability

EPS (TTM): 1.32530
Net Income (TTM): $2.4B
Gross Margin: $39.5B
Return on Equity: 144.3%
Return on Assets: 1.72%

AbbVie, Inc. Earnings Forecast

Key AbbVie, Inc. Financial Ratios

  • The Gross Profit Margin over the past 16 years for ABBV is 70.12%.
  • The Selling, General & Administrative Expenses for ABBV have been equal to 26.19% of Gross Profit Margin.
  • The Research & Development expenses have been 14.76% of Revenue.
  • The Interest Expense is 69.57% of Operating Income.
  • The Net Earning history of ABBV is 7.54% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 7 years.

AbbVie, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: ABBV
CUSIP: 00287Y
Website: abbvie.com

Debt

Debt-to-Equity Ratio: -26.02
Current Ratio: 0.72
Quick Ratio: 0.47

Price-to-Earnings

Trailing P/E Ratio: 96.32
Forward P/E Ratio: 16.16

ABBV Technical Analysis vs Fundamental Analysis

Buy
59
AbbVie, Inc. (ABBV) is a Buy

Is AbbVie, Inc. a Buy or a Sell?

  • AbbVie, Inc. stock is rated a Buy
    The current AbbVie, Inc. [ABBV] share price is $230.24. The Score for ABBV is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.